Tag: nirmatrelvir and ritonavir tablets
The US FDA committee votes in favour of the favourable benefit-risk profile of Paxlovid from Pfizer’s.
According to a report from Pfizer Inc., the Antimicrobial Drugs Advisory Committee (AMDAC) of the US Food and…
Registration Form
This will close in 0 seconds
